美股周二早盘,临床阶段生物制药公司Disc Medicine(IRON)股价小幅下跌,此前该公司宣布已定价扩大规模的证券发行,以筹集2.5亿美元,收益将用于支持抗精神分裂症药物比托派汀(Bitopertin)的商业化并推进其产品管线。此次发行包括普通股和预融资权证,交易预计将于2025年10月22日完成。

本文地址: http://www.jiaotongmi.com/article/22886.html
文章来源:admin
版权声明:除非特别标注,否则均为本站原创文章,转载时请以链接形式注明文章出处。
2025-11-13admin
2025-11-12admin
2025-11-11admin
2025-11-10admin
2025-11-09admin
2025-11-08admin
2025-11-07admin
2025-11-06admin
2025-11-05admin
2025-11-04admin
2025-09-08admin
2025-09-08admin
2025-09-13admin
2025-09-17admin
2025-09-17admin
2025-09-08admin
2025-09-09admin
2025-09-09admin
2025-09-13admin
2025-09-11admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
扫码二维码
获取最新动态
